Hong Kong Resumes Currency Intervention Spree Amid Carry Trades
The Hong Kong Monetary Authority, the city's de-facto central bank, bought HK$6.429 billion ($819 million) of the local currency on Tuesday, in addition to its purchases on Aug. 1 and July 30. That's after being absent from the market for two weeks.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Finance and foreign ministers in Mexico to talk trade ahead of Carney's visit
OTTAWA — Foreign Affairs Minister Anita Anand and Finance Minister François-Philippe Champagne are in Mexico to meet with President Claudia Sheinbaum to talk economic growth, trade and security. Their trip is happening ahead of Prime Minister Mark Carney's planned visit to Mexico to meet with Sheinbaum. The U.S. hit Canada on Friday with a 35 per cent tariff on goods not compliant with the Canada-United States-Mexico agreement on trade, known as CUSMA, while Mexico received a 90-day reprieve from threatened higher levies. CUSMA is scheduled for a mandatory review next year. Ontario Premier Doug Ford called last year for a bilateral trade deal between Canada and the United States because he said Mexico was serving as a back door for Chinese auto parts and vehicles entering the North American market. Anand and Champagne will also meet with Canadian and Mexican business leaders during the two-day trip. This report by The Canadian Press was first published Aug. 5, 2025. David Baxter, The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 minutes ago
- Yahoo
Cummins CEO Highlights Secular Growth In Power, Cautions On Truck Market Weakness
Cummins Inc. (NYSE:CMI) stock is trading higher on Tuesday after it reported second-quarter 2025 results that beat Wall Street expectations for both earnings and revenue. Strength in its Power Systems and Distribution segments offset declines in other markets. The company posted diluted earnings per share of $6.43, surpassing the $5.10 analyst estimate. Revenue for the quarter was $8.60 billion, beating the $8.43 billion consensus. Sales fell 2% year-over-year as North America declined 6%, while international sales rose 5% on higher demand in Europe and China. Also Read: Net income attributable to Cummins was $890 million, or 10.3% of sales, up from $726 million, or $5.26 per share, in the prior-year period. EBITDA for the quarter rose to $1.6 billion, or 18.4% of sales, compared with $1.3 billion, or 15.3%, a year ago. Power Systems led segment performance with sales rising 19% to $1.9 billion. North American revenue grew 23%, while international sales rose 16%, driven by demand in data center and mission-critical markets. Distribution revenue increased 7% to $3.0 billion, as North America rose 9% and international sales climbed 4%, largely due to increased demand for power generation products in the U.S. The Engine segment reported $2.9 billion in sales, down 8% year-over-year. North American revenue declined 8%, and international revenue fell 7% due to lower on-highway demand in the U.S. and Mexico. Components revenue declined 9% to $2.7 billion, with North America down 15% and flat international sales. View more earnings on CMI Accelera, Cummins' zero-emissions segment, saw sales fall 5% to $105 million due to reduced electrolyzer installations. The company reaffirmed its commitment to long-term investments under its Destination Zero strategy. Operating cash flow for the quarter was $785 million. Cummins ended the period with $2.32 billion in cash and cash equivalents and $6.81 billion in long-term debt. On July 15, the company increased its quarterly dividend from $1.82 to $2.00 per share, payable Sept. 4, 2025, to shareholders of record as of Aug. 22, marking 16 consecutive years of dividend growth. CMI also introduced the S17 Centum generator set, capable of producing up to 1 megawatt in a compact footprint for use in healthcare, water treatment, and commercial sectors. 'We see a contrast across our markets with robust demand for power generation equipment supported by clear secular drivers, and our more economically sensitive markets, such as truck, where end-user confidence has declined,' commented Chair and CEO Jennifer Rumsey. 'This contrast will become even more pronounced in the second half of the year as North America truck build rates decline sharply, starting in the third quarter,' he added. Amid ongoing economic and regulatory uncertainty, the company said it will not reinstate a full-year revenue or profitability outlook at this time. 'Our diversified portfolio, disciplined cost management and strong execution have enabled us to navigate recent industry challenges. However, persistent economic and regulatory uncertainty continues to impact a number of our key markets and cloud our near-term outlook for both business and market performance,' stated Rumsey. Price Action: At last check Tuesday, CMI shares were trading higher by 6.15% to $383.83. Read Next:Photo by JHVEPhoto via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? CUMMINS (CMI): Free Stock Analysis Report This article Cummins CEO Highlights Secular Growth In Power, Cautions On Truck Market Weakness originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
7 minutes ago
- Forbes
What's Next For HIMS Stock?
Hims & Hers stock (NASDAQ: HIMS) fell approximately 13% in after-hours trading following Q2 results that demonstrated strong growth but did not meet revenue forecasts. The company disclosed revenue of $544.8 million, which reflects a strong 73% increase compared to the previous year, although it did not reach the $552 million consensus estimate. The company's profitability metrics exhibited considerable enhancement. Adjusted EBITDA hit $82 million, more than doubling from $39.3 million in the same quarter last year. This resulted in earnings per share of $0.17, exceeding both the $0.15 consensus estimate and the $0.06 registered in the same quarter last year. Separately, see – UNH Stock To $160? HIMS continues to gain significant benefits from compounded GLP-1 sales — less expensive, unapproved versions of well-known diabetes and weight loss drugs. Although this revenue channel has fueled notable growth, it also poses a critical risk to the company's business model. The short-lived partnership with Novo Nordisk, which ended after a few months, underscored the regulatory and competitive challenges that come with the company's dependence on compounded alternatives. The viability of this strategy is now uncertain as regulatory oversight intensifies and established pharmaceutical manufacturers may challenge the compounded sector. In spite of the recent downturn, HIMS trades at premium valuations that seem disconnected from overall market measures: At current levels around $55, the stock is still above the average analyst price target of roughly $50, indicating potential further downside risk even after the recent drops. Also, see – Buy or Sell HIMS Stock? While HIMS has shown remarkable revenue growth, several aspects necessitate caution. The company's reliance on compounded medications introduces regulatory uncertainty, and the valuation metrics imply that the stock remains costly when compared to both the broader market and analyst predictions. The significant improvements in profitability offer some support, but investors are paying a considerable premium for growth that could encounter challenges if regulatory conditions change or branded competitors take a more aggressive approach to the compounded market. See, there always remains a significant risk when investing in a single stock, or just a few stocks. Consider Trefis High Quality (HQ) Portfolio which, featuring a collection of 30 stocks, has a history of comfortably outperforming the S&P 500 over the past 4 years. Why is that? As a collective, HQ Portfolio stocks have delivered better returns with lower risk compared to the benchmark index; avoiding dramatic fluctuations, as illustrated by HQ Portfolio performance metrics.
